COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Announces Amendment to Pure Sunfarms’ Cultivation License, Substantially Expanding Cannabis Production Area to Approximately 420,000 Square Feet
23/08/2018
VICTORIA, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) and Village Farms International, Inc. (TSX:VFF) (OTC: VFFIF) today announced that their [...]
Innovate Biopharmaceuticals Enters into an Agreement with Amarex Clinical Research for Data Management and Biostatistics for Phase 3 Celiac Disease Trial
23/08/2018
RALEIGH, N.C., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases [...]
Emblem Corp. Advances Funding for Natura Naturals Production
23/08/2018
TORONTO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) (“ Emblem ” or the “ Company ”) has established a working capital advance (the “ Advance ”) for Natura Naturals Holdings Inc. (“ Natura [...]
PCI Biotech: Invitation to first half year 2018 presentation
23/08/2018
Oslo, 23 August 2018 - PCI Biotech invites to a presentation of the company's second quarter and first half year 2018 report on Thursday 30 August 2018 at Oslo Cancer Cluster Innovation Park. Time: Thursday August 30, [...]
Acarix presenting the CADScor®System at ESC in Munich: A revolutionary technology for early and rapid rule out of Coronary Artery Disease
23/08/2018
Press release Malmö, Sweden August 23, 2018 Acarix presenting the CADScor®System at ESC in Munich: A revolutionary technology for early and rapid rule out of Coronary Artery Disease Visit us at booth D500 Exhibition [...]
Adherium and Vitalus Health Launch Commercial Program to Support Patients with Asthma and COPD
23/08/2018
SAN MATEO, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR) a digital health platform focused on improving medication adherence and patient outcomes, and Vitalus Health, a leading provider of comprehensive [...]
Major shareholding announcement
23/08/2018
Company announcement 23 August 2018 Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to have received a major [...]
Notice convening an Extraordinary General Meeting of NeuroSearch A/S
23/08/2018
Company announcement 23 August 2018 Pursuant to Articles 8 and 10 of the Articles of Association, notice is hereby given of an Extraordinary General Meeting to be held on 14 September 2018, at 11 a.m. at Kromann Reumert [...]
Shire plc: Rule 2.9 Announcement
23/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 August 2018 [...]
Ambu A/S: Interim report Q3 2017/18
23/08/2018
Ambu reports organic growth of 17% in Q3 and raises its outlook for this year's EBIT margin by 1 percentage point. Moreover, the target for sales of endoscopes is increased to 550,000 units. "Our business is moving [...]
SOLAR-1 trial of Novartis investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) meets primary endpoint in HR+/HER2- advanced breast cancer with PIK3CA mutation
23/08/2018
SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients with PIK3CA mutations who progressed on or following treatment with an aromatase inhibitor with or without a [...]
INNATE PHARMA ANNOUNCES A CHANGE TO ITS 2018 FINANCIAL CALENDAR
23/08/2018
Innate Pharma announces a Change to its 2018 financial calendar Marseille, France, August 23, 2018 Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announced a change to its 2018 financial [...]
INNATE PHARMA ANNONCE UNE MODIFICATION DE SON CALENDRIER FINANCIER 2018
23/08/2018
Innate Pharma annonce une Modification de son calendrier financièr 2018 Marseille le 23 août 2018 Innate Pharma SA (la « Société » - Euronext Paris : FR0010331421 - IPH) annonce une modification de son calendrier de [...]
IBA SA : IBA Reports Half Year Results for 2018
23/08/2018
IBA Reports Half Year Results for 2018 Group revenue of EUR 115 million, with revenues weighted to H2 Five Proteus ® ONE solutions sold in the period, of which three contracts are awaiting financing and one is a term [...]
IBA SA : IBA annonce ses résultats semestriels pour 2018
23/08/2018
IBA annonce ses résultats semestriels pour 2018 Des revenus d'EUR 115 millions pour le Groupe, avec une pondération des revenus sur S2 Cinq solutions Proteus ® ONE vendues au cours du semestre dont trois contrats en [...]
Probiodrug AG to Publish First Half 2018 Results on August 30, 2018
23/08/2018
Probiodrug AG to Publish First Half 2018 Results on August 30, 2018 HALLE (SAALE), Germany, 23 August 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel [...]
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
23/08/2018
Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), wishes to remind investors and shareholders [...]
Merus annonce la création d'un comité consultatif scientifique
23/08/2018
- Des oncologues et des professionnels du développement pharmaceutique clés vont apporter leur soutien aux progrès du pipeline d'anticorps bispécifiques de Merus - UTRECHT, Pays-Bas, 23 août 2018 (GLOBE NEWSWIRE) -- [...]
Vigil Health Solutions Completes 2018 AGM
23/08/2018
VICTORIA, British Columbia, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”), is pleased to announce that, at its 2018 AGM shareholders elected Troy Griffiths, Greg Peet, Ian Power and Lindsay [...]

Pages